A journey of a thousand miles begins with a single step, and a big one in this case. BioLineRx (BLRX) announced this morning that …
Written by Danny Cohen of stockmatusow.com BiolineRx (BLRX) is slated to report on complete data at the European Society for Medical Oncology (ESMO) …
Bioline RX Ltd (NASDAQ:BLRX) is officially turning its Phase 3 GENESES clinical trial’s wheels, with the Israeli drug maker revealing today the launch …
Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reports its financial results for the …
Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced that it will present positive …
Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced the presentation of positive safety and …
Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced that research underlying BL-9020, for the …
Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced the publication of positive results …
Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced that positive safety and efficacy Phase …
Bioline RX Ltd (NASDAQ:BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, reports its financial results for the first …
